DAFTAR PUSTAKA

1. Ezzedin K and Harris JE. Vitiligo. In: Kang S, Amagai M, Bruckner AL, Enk
35 AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick
Dermatology. Ed 9th. New York: McGraw Hill. 2019:1330-50
2. Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo
in children/adolescents and adults. Int J Dermatol. 2012 Oct;51(10):1206-12
3. Rizal Y, Lestari S. Insidensi vitiligo di poliklinik kulit dan kelamin RSUP Dr.
M Djamil Padang tahun 2001-2006. MDVI. 2008; Januari 35 (1): 77.
4. Sandoval M. Immunopathogenesis of vitiligo. Autoimmun Rev. 2011
Oct;10(12):762–5.
5. Sravani PV. Determination of oxidative stress in vitiligo by measuring
superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous
skin. Indian J Dermatol Venereol Leprol Dermatol. 2009;75:268-71.
6. Olasade A. Dermatology Psychosocial problems in patients with vitiligo in
Nigeria. Sudan J Dermatol. 2007;5:51-8
7. Kruger C, Schallreuter KU. Cumulative life course impairment in vitiligo. Curr
Probl Dermatol. 2013;44:102–17
8. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality
Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol.
2003;148:373-4
9. Suman B, Pranjal D, Rakesh M. Assessment of Quality of Life in Vitiligo
patients attending a tertiary care hospital – a cross sectional study. Ind
Psychiatry Journal. 2021;30(1):62-66
10. Asri E, Kampar P. Hubungan Vitiligo Area Scoring Index (VASI) dengan
Dermatology Life Question Index (DLQI) pada pasien vitiligo di
RSUP.Dr.M.Djamil Padang Periode 2015-2016. Jurnal Kesehatan Andalas.
Vol 8 (3) 2019;1-5
11. Nurina DR, Rahmadewi R. Studi Retrospektif: Profil pasien baru vitiligo.
Periodical of Dermatology and Venereology.2022;28(2):130-6
12. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published
work. Journal of Dermatology. 2011;38:419-31.
13. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo Working
Group. Current and emerging treatments for vitiligo. J Am Acad Dermatol.
2017 Jul;77(1):17–29.
14. Whitton M, Pinart M, Batchelor J.M, Leonardi J, Gonzalez U, Jiyad Z.
Evidance based management of vitiligo:summary of a cochrane systematic
review. Br. J. Dermatol. 174 (5):962-69
15. Zhu Y, Wang S, Xu A. A mouse model of vitiligo induced by monobenzone.
Exp. Dermatol. 2021(7).499-501.
16. Yaobin P, Shi w, Yingjie H, Qing N, Jing L, Yejing Y, et al. Plant-derived
compounds as promising Therapeutics for vitiligo. Frontiers in
Pharmacology.2021.
17. Riding L,RichardM, Harris J. Mouse Model for Human Vitiligo. Curr. protoc.
Immunol. 2019 Feb;124(1)
18. Reddy J, Ranganathan, Jeldi H. A study of phytochemical analysis and
antioxidant potentials of use in the treatment of vitiligo. European Journal of
Biomedical and pharmaceutical sciences. 2014 Dec;1:471-9
19. Zhu Y, Zhong L, Peng J, Yuan Q, Xu A. The therapeutic effect baicalin on
vitiligo mice. Biol Pharma.Bull. 2019 Sep 1;42(9):1450-5
20. Huo S.X, Wang Q. The Effect of Butin on the Vitiligo Mouse Model Induced
by Hydroquinone. Phytother. Res. 2017;31 (5): 740–6.
21. Kowichi J, Hiroko, Madhu A, Pathak, Thomas B. Fitzpatrick. Mechanism of
depigmentation by Hydroquinone. Journal of Investigative Dermatology.1974;
62(4):436-449
22. Sun B, Lili W, You W, Chengfei, Lingling Q, Misa H et al. Therapeutic
Potential of Centella asiatoca and its Triterpenes : A Review. Frontier in
Pharmacology.2020.
23. James J.T, Dubery I.A. Psentacyclic triterpenoid froms the medicinal herb,
Centella asiatica (L) urban. Molecules.2009;14:3922-41
24. Bylka W, Znajdek P, Studzinska Sroka E, Danczak-Pazdrowska A..Centella
asiatica in Dermatology: An Overview. Phytotherapy Research, 2014; 28(8):
1117–24.
25. Menteri Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik
Indonesia Nomor 6 Tahun 2016 Tentang Formularium Obat Herbal Asli
Indonesia, Jakarta;2016.
26. Azis, Taher M, Ahmed AS, Sulaiman, Susanti, Chowdry,et al. In vitro and in
vivo wound healing studies of methanolic fraction of centella asiatica extract.
South african journal of Botany,2017,109.163-74
27. Ling Y, Gong Q, Xiong X, Sun L, Zhao W, Zhu W, et al. Protective effect of
madecassoside on H2O2-induced oxidative stress and autophagy activation in
human melanocytes. Oncotarget. 2017; (31): 51066–51075.
28. Putri V. Formulasi krim ekstrak etanol herba pegagan (centella asiatica (L.)
urban) konsentrasi 6% dan 10% dengan basis cold krim dan vanishing krim
serta uji aktivitas antibakteri terhadap staphilokokus aureus. Skripsi.
Universitas Muhammadiya Surakarta.2013
29. Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive
overview part I. Introduction, epidemiology, quality of life, diagnosis,
differential diagnosis, associations, histopathology, etiology, and work-up. J
Am Acad Dermatol. 2011 Sep;65(3):473-91.
30. Kyriakis KP, Palamaras L, Tsele E, Michailides C, Terzoudi S. Case detection
rates of vitiligo by gender and age. Int J Dermatol. 2009 Mar;48(3):328-9.
31. Jin Y, Roberts G, Ferrara, Ben S, Geel N, Wolkerstofer A. Early onset
autoimmune vitiligo associated with an enhancer variant haplotype that
upregulates class II HLA expression.Nature Communication.2019(10).391
32. Baum S, Barzilai A, Trau H. Vitiligo. In : Shoenfeld Y, Cervera R, Gershwin
ME, editors. Diagnostic criteria in autoimmune diseases.2008 Oct 01.p. 353-8.
33. Gauthier, Y, Andre C, Taieb, A. A Critical Appraisal of Vitiligo Etiologic
Theories. Is Melanocyte Loss a Melanocytorrhagy Pigment Cell
Research.2003; 16(4): 322–332.
34. Haider N, Islam MS, Al-Maraf A, Shohag MH, Ali R, Rahman GKMM, Hasnat
A. Oxidative stress and antioxidant status in vitiligo patients. Dhaka Univ J
Pharm Sci. 2010 Dec; 9(2): 103-8.
35. Naini FF, Shooshtari AV, Ebrahimi B, Molaei R. The effect of
pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study.
J Res Pharm Pract. 2012 Oct-Dec; 1(2): 77–80.
36. Amin MZ, Rahman MH, Satter MA. Study of some biochemical parameters of
vitiligo patients in Bangladesh. Bangladesh J Sci Ind Res. 2012.Oct 20; 47(2):
173-86.
37. Khan R, Satyam A, Gupta S, Sharma VK, Sharma A. Circulatory levels of
antioxidants and lipid peroxidation in Indian patients with generalized and
localized vitiligo. Arch Dermatol Res. 2009 Oct;301(10):731-7.
38. Taieb A, Alomar, Bohm M, Dell A, Passe D, Eleftheriadou, et al. Guidelines
for the management of vitiligo : the European dermatology forum concencus.
BJD.2012 July;168:5-19
39. Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin
diseases. What’s new. J Eur Acad Dermatol Venereol. 2003 Nov;17(6):663-9.
40. Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published
work. Journal of Dermatology. 2011;38:419-31.
41. Adriane R, Roberto G, Gersan. Vitiligo Part 2- classification, histopathology
and treatment. An Bras Dermatol. 2014;89(5):784-90
42. Orhan.,Centella asiatica (L.) Urban: From Traditional Medicine to Modern
Medicine with Neuroprotective Potential. Hindawi Publishing
Corporation.March 2012
43. Susetyorini E., Latifa R., Wahyono P., Nurrohman E., Atlas Morfologi
Anatomi Pegagan.2020. p:1-20
44. Brinkhaus B,Lindner M,Schuppan D,Hahn EG.Chemical, pharmacological and
clinical profile of the East Asian medical plant Centella
asiatica. Phytomedicine. 2000;75:427–48
45. James J, Dubery I. Identification and quantification of triterpenoid Centelloids
in Centella asiatica (L.) urban by densitometric TLC. J Planar
Chromatogr. 2011;24:82–7.
46. Hashin P, Sidek H, Helan MH. Triterpene composition and bioactive of
Centella asiatica. Molecules. 2011;16:1310–22.
47. Aida LW, Wan A, Muhammad I. Review on Pharmacological and Potential
Cosmeceutical Values of Centella asiatica.Int.J.Pharm.2022 Vol 5(1):13-32
48. Bylka A.W, Znajdek-Awizen P, Studzińska-Sroka E, Danczak-Pazdrowska A,
Brzezińska M. Centella asiatica in dermatology: an overview. Phytother Res.
2014 Aug;28(8):1117-24.
49. Ahmed A, Taher M, Mandal K, Jaffri J, Susanti D, Mahmood S., et al.
Pharmacological properties of Centella asiatica hydrogel in accelerating wound
healing in rabbits. BMC Complement. Altern. Med.2019: 19 (1), 1–7.
50. Park J. Anti-inflammatory effect of titrated extract of Centella asiatica in
phthalic anhydride-induced allergic dermatitis animal model. Int. J. Mol.
Sci.2017;18 (4): 1–14.
51. Committee on Herbal Medicinal Product. Asessment report on centella asiatica
(L.) Urban, herba. 44European Medicines Agency.2010.p:1-44
52. Fredrico P, Rafael C, Dutra D, Junior , Miriam T. Antioxidant and cytotoxic
activity of centella asiatica. Int. J. Mol. Sci. 2009. 10 (9), 3713-3721
53. Lee T, Seo J, Baek S, Kim S. Inhibitory effects of resveratrol on melanin
synthesis in ultraviolet B-induced pigmentation in guinea pig skin.
Biomolecules and Therapeutics, 2014.22(1), pp. 35–40.
54. Oyenihi P, Chegu NN, Oguntibeju, Masola B. Centella asiatica enhances
hepatic antioxidant status and regulates hepatic inflammatory cytokines in type
2 diabetic rats. Pharm Biol. 2017 Dec:55 (1):1671-1678
55. Marasri J, Sunisa S. Development of herbal juice from centella asiatica :
antioxidant property and nutritional. Food science and technology.2022
56. Hong B, Li Y, Zhao H. Primary antioxidant free radical scavening and redoks
signaling pathways in higher plant cell. International journal of biological
sciences.2018;Dec:4(1);p:8-14
57. Hussin M, Azizah A, Suhaila M,Nazamid S, Mznah I, Hairi B. Protective effect
of centella asiatica extract and powder on oxidative stress in rats. Journal food
chemistry.2007;p:535-541
58. Jhon E, Harris. Chemical induce vitiligo. Dermatol clin, 2017 April; 35(2):151-
161